<DOC>
	<DOCNO>NCT00522275</DOCNO>
	<brief_summary>The purpose trial determine whether lacosamide safe effective long-term use patient partial-seizures epilepsy</brief_summary>
	<brief_title>Determine Safety Efficacy Long-term Oral Lacosamide Patients With Partial Seizures</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Epilepsies , Partial</mesh_term>
	<mesh_term>Lacosamide</mesh_term>
	<criteria>Completion parent clinical trial treatment partial seizure Receiving study drug experimental device lacosamide Meets withdrawal criterion parent trial experience ongoing serious adverse event</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Adjunctive treatment epilepsy</keyword>
	<keyword>add-on treatment epilepsy</keyword>
	<keyword>partial seizure</keyword>
	<keyword>AEDs</keyword>
	<keyword>antiepileptic drug</keyword>
	<keyword>seizure</keyword>
</DOC>